There are 2789 resources available
Invited Discussant 118O and 119O
Presenter: Monica Arnedos
Session: Proffered Paper session - Breast cancer, early stage
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Monica Arnedos
Session: Proffered Paper session - Breast cancer, early stage
Resources:
Slides
Webcast
Invited Discussant LBA23 and 512O
Presenter: Christophe Massard
Session: Proffered Paper session - Developmental therapeutics
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Christophe Massard
Session: Proffered Paper session - Developmental therapeutics
Resources:
Slides
Webcast
Invited Discussant 513O and 514O
Presenter: Elena Garralda
Session: Proffered Paper session - Developmental therapeutics
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Elena Garralda
Session: Proffered Paper session - Developmental therapeutics
Resources:
Slides
Webcast
514O - An open-label, global, first-in-human study of SKB264 in patients with locally advanced or metastatic solid tumors
Presenter: Jordi Rodon
Session: Proffered Paper session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
958O - Coordinated activation of antitumor responses of g9d2 and CD8 T-cells by targeting BTN3A with ICT01 in patients with solid tumors: EVICTION trial
Presenter: Aurélien Marabelle
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
959O - Gavocabtagene autoleucel (gavo-cel, TC-210) dose escalation in refractory mesothelin-expressing solid tumors
Presenter: David S. Hong
Session: Proffered Paper session - Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
LBA11 - Individual patient data meta-analysis of 5 non-inferiority RCTs of reduced duration single agent adjuvant trastuzumab in the treatment of HER2 positive early breast cancer
Presenter: Helena Earl
Session: Proffered Paper session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast